Skip to content

Coxiella burnetii Phase 2 IgG Control Serum BC1312G

$94.00

Summary

  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Coxiella burnetii Phase 2 IgG Control Serum
  • Applications: ELISA
  • IgG control serum
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL
SKU: BC1312G Categories: , Tags: , ,
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Coxiella burnetii Phase 2 reactive IgG

species reactivity

Coxiella burnetii (Q fever)

applications

ELISA

assay type

Indirect & quantitative

available size

3 mL

Coxiella burnetii Phase 2 IgG Control Serum BC1312G

kit
Research area
Infectious Disease
Storage
Store at 2-8°C.
Associated products
Coxiella burnetii Phase 2 IgG Control Serum (BC1312G)
Coxiella burnetii Phase 2 IgM Control Serum (BC1312M)
Coxiella burnetii IgA Phase I ELISA Kit (ESR1311A)
Coxiella burnetii IgG Phase I ELISA Kit (ESR1311G)
Coxiella burnetii IgG Phase II ELISA Kit (ESR1312G)
Coxiella burnetii IgM Phase II ELISA Kit (ESR1312M)
target relevance
Organism
Coxiella burnetii
Protein names
Coxiella burnetii
Structure and strains
Coxiella burnetii is an obligate intracellular bacterial pathogen, and is the causative agent of Q fever. The genus Coxiella is morphologically similar to Rickettsia, but with a variety of genetic and physiological differences. C. burnetii is a small Gram-negative, coccobacillary bacterium that is highly resistant to environmental stresses such as high temperature, osmotic pressure, and ultraviolet light. These characteristics are attributed to a small cell variant form of the organism that is part of a biphasic developmental cycle, including a more metabolically and replicatively active large cell variant form. It can survive standard disinfectants, and is resistant to many other environmental changes like those presented in the phagolysosome.
Detection and diagnosis
The diagnosis of Q fever is performed by the demonstration of specific antibodies directed against Coxiella burnetii. Due to variations in the lipopolysaccharide (LPS) structure on the surface of the pathogen, as the disease enters the chronic state, a serological differentiation of acute from chronic infections is possible. Due to the high sensitivity and specificity, the use of ELISA immunoassays is recommended by the World Health Organization (WHO). Following the regular course of an acute primary infection, specific IgM and IgG antibodies directed against the immunogenic phase 2 antigens can be demonstrated. IgG antibodies directed against phase 2 antigens often persist over several years. In the lead-up to a chronic infection, IgG and IgA antibodies directed against the phase 1 antigens appear, which are of diagnostic value particularly for the diagnosis of Q fever endocarditis

Data

Publications

Publications

pmid title authors citation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC1312G protocol

Documents

#
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information.